Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Fritsch

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|April 17, 2008
[Progress in diagnostics of anorectal disorders. Part I: anatomic background and clinical and neurologic procedures]F G Bader, R Bouchard, R Keller, et al.
Onkologie|April 1, 1987
5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)"H Flechtner, W Queisser, M E Heim, et al.
The Journal of Urology|June 19, 2007
Fetal distribution of 5alpha-reductase 1 and 5alpha-reductase 2, and their input on human prostate developmentA Lunacek, C Schwentner, J Oswald, et al.
Cell and Tissue Research|September 20, 2017
Role of BDNF and neurotrophic receptors in human inner ear developmentL Johnson Chacko, M J F Blumer, E Pechriggl, et al.
Der Urologe. Ausg. A|November 19, 2004
[Stem cell therapy for urinary incontinence]H Strasser, R Marksteiner, E Margreiter, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 28, 2010
Pancreatic graft survival despite partial vascular graft thrombosis due to splenocephalic anastomosesC Margreiter, W Mark, D Wiedemann, et al.
British Journal of Cancer|April 24, 2014
A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignanciesC-C Lin, W-C Su, C-J Yen, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|April 17, 2008
[Progress in diagnostics of anorectal disorders. Part I: anatomic background and clinical and neurologic procedures]F G Bader, R Bouchard, R Keller, et al.
Onkologie|April 1, 1987
5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)"H Flechtner, W Queisser, M E Heim, et al.
The Journal of Urology|June 19, 2007
Fetal distribution of 5alpha-reductase 1 and 5alpha-reductase 2, and their input on human prostate developmentA Lunacek, C Schwentner, J Oswald, et al.
Cell and Tissue Research|September 20, 2017
Role of BDNF and neurotrophic receptors in human inner ear developmentL Johnson Chacko, M J F Blumer, E Pechriggl, et al.
Der Urologe. Ausg. A|November 19, 2004
[Stem cell therapy for urinary incontinence]H Strasser, R Marksteiner, E Margreiter, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 28, 2010
Pancreatic graft survival despite partial vascular graft thrombosis due to splenocephalic anastomosesC Margreiter, W Mark, D Wiedemann, et al.
British Journal of Cancer|April 24, 2014
A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignanciesC-C Lin, W-C Su, C-J Yen, et al.
Pageof 14